Italom 50 Capsule contains Itraconazole 50mg, a potent broad-spectrum antifungal agent used to treat systemic and superficial fungal infections. Itraconazole inhibits fungal cell membrane synthesis, effectively stopping the growth and spread of Candida, Aspergillus, and other pathogenic fungi.
This Tablet falls under the antifungal segment, offering effective therapy for infections such as oral thrush, esophageal candidiasis, dermatophytosis, and systemic mycoses. Its oral formulation ensures patient convenience, adherence, and high bioavailability for faster recovery.
Healthcare professionals prefer Italom 50 Capsule due to its consistent efficacy, safety profile, and ability to manage both acute and chronic fungal infections. It is widely prescribed in hospitals, clinics, and specialty centers, making it a high-demand pharmaceutical product.
For B2B partners, Italom 50 Capsule provides a profitable opportunity in the antifungal segment. Its strong clinical acceptance, repeat prescription rate, and inclusion in PCD pharma franchise portfolios ensure steady business growth. Export and third-party manufacturing prospects further enhance its market potential, offering high-margin returns in domestic and international markets.